A citation-based method for searching scientific literature

Gregory E Idos, Allison W Kurian, Charité Ricker, Duveen Sturgeon, Julie O Culver, Kerry E Kingham, Rachel Koff, Nicolette M Chun, Courtney Rowe-Teeter, Alexandra P Lebensohn, Peter Levonian, Katrina Lowstuter, Katlyn Partynski, Christine Hong, Meredith A Mills, Iva Petrovchich, Cindy S Ma, Anne-Renee Hartman, Brian Allen, Richard J Wenstrup, Johnathan M Lancaster, Krystal Brown, John Kidd, Brent Evans, Bhramar Mukherjee, Kevin J McDonnell, Uri Ladabaum, James M Ford, Stephen B Gruber. JCO Precis Oncol 2019
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
Niki M Medendorp, Pomme E A van Maarschalkerweerd, Laxsini Murugesu, Joost G Daams, Ellen M A Smets, Marij A Hillen. Patient Educ Couns 2020
5
100

Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
Claire C Conley, Monica L Kasting, Bianca M Augusto, Jennifer D Garcia, Deborah Cragun, Brian D Gonzalez, Jongphil Kim, Kimlin Tam Ashing, Cheryl L Knott, Chanita Hughes-Halbert,[...]. Ann Surg Oncol 2020
3
50

Variant Interpretation: Functional Assays to the Rescue.
Lea M Starita, Nadav Ahituv, Maitreya J Dunham, Jacob O Kitzman, Frederick P Roth, Georg Seelig, Jay Shendure, Douglas M Fowler. Am J Hum Genet 2017
114
50

Physician interpretation of variants of uncertain significance.
Sarah K Macklin, Jessica L Jackson, Paldeep S Atwal, Stephanie L Hines. Fam Cancer 2019
26
50

Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing.
Jada G Hamilton, Jessica M Long, Amanda C Brandt, Jamie Brower, Heather Symecko, Erin E Salo-Mullen, Stephanie N Christian, Tricia Harstad, Fergus J Couch, Judy E Garber,[...]. JCO Precis Oncol 2019
10
50

Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
67
50

Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.
Marissa Howard-McNatt, Rebecca W Schroll, Gail J Hurt, Edward A Levine. Am J Surg 2011
17
50

Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
David J Hermel, Wendy C McKinnon, Marie E Wood, Marc S Greenblatt. Fam Cancer 2017
11
50

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
81
50

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
50


Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
50

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
831
50

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
129
50

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
110
50

Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
Patricia A Parker, Susan K Peterson, Isabelle Bedrosian, Melissa A Crosby, Yu Shen, Dalliah M Black, Gildy Babiera, Henry M Kuerer, Jun Ying, Wenli Dong,[...]. Ann Surg 2016
51
50

Risk management decisions in women with BRCA1 and BRCA2 mutations.
Rosemary Morgan, Audrey Brown, Kelly Jo Hamman, Jone Sampson, Arpana Naik, Kristen Massimino. Am J Surg 2018
3
50

The influence of BRCA variants of unknown significance on cancer risk management decision-making.
Jing Yi Chern, Sarah S Lee, Melissa K Frey, Jessica Lee, Stephanie V Blank. J Gynecol Oncol 2019
7
50

Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Brittany L Murphy, Min Yi, Banu K Arun, Angelica M Gutierrez Barrera, Isabelle Bedrosian. Ann Surg Oncol 2020
4
50

Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.
Holly J Pederson, Dharmesh Gopalakrishnan, Ryan Noss, Courtney Yanda, Charis Eng, Stephen R Grobmyer. J Am Coll Surg 2018
13
50

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Nisreen Elsayegh, Rachel D Webster, Angelica M Gutierrez Barrera, Heather Lin, Henry M Kuerer, Jennifer K Litton, Isabelle Bedrosian, Banu K Arun. Cancer Med 2018
11
50

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
174
50

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
803
50

Adverse events in cancer genetic testing: the third case series.
Danielle C Bonadies, Karina L Brierley, Rachel E Barnett, Melanie D Baxter, Talia Donenberg, Whitney L Ducaine, Michelle E Ernst, Jeanne Homer, Megan Judkins, Niki M Lovick,[...]. Cancer J 2014
26
50


Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
50

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Stephanie M Wong, Rachel A Freedman, Yasuaki Sagara, Fatih Aydogan, William T Barry, Mehra Golshan. Ann Surg 2017
162
50

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
50


Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Jessemae L Welsh, Tanya L Hoskin, Courtney N Day, Abigail S Thomas, Jodie A Cogswell, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2017
34
50

Impact of an embedded genetic counselor on breast cancer treatment.
Holly J Pederson, Najaah Hussain, Ryan Noss, Courtney Yanda, Colin O'Rourke, Charis Eng, Stephen R Grobmyer. Breast Cancer Res Treat 2018
17
50

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
50

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
Kandice K Ludwig, Joan Neuner, Annabelle Butler, Jennifer L Geurts, Amanda L Kong. Am J Surg 2016
78
50

Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
S Richter, I Haroun, T C Graham, A Eisen, A Kiss, E Warner. Ann Oncol 2013
60
50

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
68
50

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
302
50

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Bent E Fiane, Turid Aas, Kathrine Woie, Helge Espelid, Tone Rusken, Hans Petter Eikesdal, Wenche Listøl, Marianne T Haavind,[...]. Eur J Hum Genet 2016
37
50


Re-examining the Ethics of Genetic Counselling in the Genomic Era.
Will Schupmann, Leila Jamal, Benjamin E Berkman. J Bioeth Inq 2020
5
50

Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review.
Adam Hudson Buchanan, Alanna Kulchak Rahm, Janet L Williams. Front Oncol 2016
57
50

Genetic Counseling Service Delivery Models in the United States: Assessment of changes in use from 2010 to 2017.
Samantha E Greenberg, Emily Boothe, Christine L Delaney, Ryan Noss, Stephanie A Cohen. J Genet Couns 2020
11
50

Mainstreamed genetic testing in ovarian cancer: patient experience of the testing process.
Laura McLeavy, Belinda Rahman, Rebecca Kristeleit, Jonathan Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side, Anne Lanceley. Int J Gynecol Cancer 2020
4
50

Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
Tahlia Scheinberg, Alison Young, Henry Woo, Annabel Goodwin, Kate L Mahon, Lisa G Horvath. Asia Pac J Clin Oncol 2021
5
50

Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale.
Tiffani A DeMarco, Beth N Peshkin, Bryn D Mars, Kenneth P Tercyak. J Genet Couns 2004
62
50

Cancer patients' expectations when undergoing extensive molecular diagnostics-A qualitative study.
Amy Rohrmoser, Theresia Pichler, Anne Letsch, C Benedikt Westphalen, Ulrich Keilholz, Volker Heinemann, Ute Goerling, Peter Herschbach. Psychooncology 2020
3
50

Analysis of Advantages, Limitations, and Barriers of Genetic Counseling Service Delivery Models.
Stephanie A Cohen, Rachelle C Huziak, Shanna Gustafson, Robin E Grubs. J Genet Couns 2016
35
50

Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics.
Jada G Hamilton, Mark E Robson. Hastings Cent Rep 2019
7
50

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
82
50

Quality of Life in Patients With Pancreatic Cancer and Their Caregivers: A Systematic Review.
Margaret R Bauer, Emma E Bright, James J MacDonald, Elizabeth H Cleary, O Joe Hines, Annette L Stanton. Pancreas 2018
24
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.